Engineering γδ T Cells: Recognizing and Activating on Their Own Way
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2022.889051
Abstract: Adoptive cell therapy (ACT) with engineered T cells has emerged as a promising strategy for the treatment of malignant tumors. Among them, there is great interest in engineered γδ T cells for ACT. With both… read more here.
Keywords: engineered cells; engineering cells; cells recognizing; recognizing activating ... See more keywords